BS
Boston Scientific
BSX · NYSE
$47.81 +1.82% (+$0.86)
1M -5.27%
Market Cap $71.1B
P/E Ratio 19.38x
Div. Yield -
ROE 14.90%
Bulios Fair Price
$31.46
34.2% downside
Trenutna cena
$47.81
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BSX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
64 /100
Fair EV/EBITDA 14.63x
P/S 3.38x
P/B 2.85x
Growth
97 /100
Growing Rev. growth 16.54%
FCF growth 58.77%
Book val. growth 11.30%
Profitability
95 /100
Strong Net margin 17.47%
Op. margin 21.46%
FCF margin 17.27%
Quality
61 /100
Average ROE 14.90%
ROA 8.11%
Asset turnover 0.46x
Debt
74 /100
Low Current ratio 1.24x
Int. coverage 12.09x
Net debt/EBITDA 2.13x
Stability
72 /100
Stable Rev. volatility 3.89%
EPS volatility 63.49%
Profitable years 5
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BSX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Michael F. Mahoney
Employees
59,000
Headquarters
Marlborough
Prihajajoči dogodki
28 OKT.
Earnings
Upcoming earnings report